Document:

Warrant to Purchase Stock

 Exhibit 4.5 
 THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AND PURSUANT TO
THE PROVISIONS OF ARTICLE 5 BELOW, MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND APPLICABLE STATE SECURITIES LAW OR, IN THE OPINION OF LEGAL COUNSEL IN FORM AND SUBSTANCE
SATISFACTORY TO THE ISSUER OF THESE SECURITIES, SUCH OFFER, SALE OR TRANSFER, PLEDGE OR HYPOTHECATION IS EXEMPT FROM REGISTRATION. 
 WARRANT TO PURCHASE STOCK 
 Company: Jive Software, Inc., a Delaware corporation

 Number of Shares: 127,000, subject to adjustment 
 Class of Stock: Common Stock, $0.0001 par value per share 
 Warrant Price: $7.8707, subject to
adjustment 
 Issue Date: May 17, 2011 
 Expiration Date: As set forth in Article 5.1 below 

			
	 Credit Facility:
	 	This Warrant is issued in connection with that certain Fifth Loan Modification Agreement, of even date herewith, to that certain Amended and Restated Loan and Security Agreement
dated October 14, 2008 between Silicon Valley Bank and the Company (as further modified and/or amended and in effect from time to time, the “Loan Agreement”).

 THIS WARRANT CERTIFIES THAT, for good and valuable consideration, SILICON VALLEY BANK
(Silicon Valley Bank, together with any successor or permitted assignee or transferee of this Warrant or of any shares issued upon exercise hereof, is referred to hereinafter as “Holder”) is entitled to purchase up to the number of fully
paid and non-assessable shares (the “Shares”) of the above-stated Class of Stock (the “Class”) of the above-named company (the “Company”) at the above-stated Warrant Price per Share, subject to the provisions and upon
the terms and conditions set forth in this Warrant. 
 ARTICLE 1. EXERCISE. 

1.1 Method of Exercise. Holder may exercise this Warrant by delivering the original of this Warrant together with a
duly executed Notice of Exercise in substantially the form attached as Appendix 1 to the principal office of the Company. Unless Holder is exercising the conversion right set forth in Article 1 .2, Holder shall also deliver to the Company a check,
wire transfer (to an account designated by the Company), or other form of payment acceptable to the Company for the aggregate Warrant Price for the Shares being purchased. 

1 .2 Conversion Right. In lieu of exercising this Warrant as specified in Article 1.1, Holder may from time to
time convert this Warrant, in whole or in part, into a number of Shares determined by dividing (a) the aggregate fair market value of the Shares or other securities otherwise issuable upon exercise of this Warrant minus the

 
aggregate Warrant Price of such Shares by (b) the fair market value of one Share. The fair market value of the Shares shall be determined pursuant to Article 1.3. 

1.3 Fair Market Value. If shares of the Class are then traded in a public market, the fair market value of a Share
shall be the closing price of a share of the Class reported for the business day immediately before Holder delivers this Warrant together with its Notice of Exercise to the Company (or in the instance where the Warrant is exercised immediately prior
to the effectiveness of the Company’s initial, underwritten offering and sale of its shares to the public pursuant to an effective registration statement under the Securities Act of 1933, as amended (“IPO”), the “price to
public” per share price specified in the final prospectus relating to such offering). If shares of the Class are not then traded in a public market, the Board of Directors of the Company shall determine fair market value in its reasonable good
faith judgment. 
 1.4 Delivery of Certificate and New Warrant. Promptly after Holder exercises or
converts this Warrant and, if applicable, the Company receives payment of the aggregate Warrant Price, the Company shall deliver to Holder certificates for the Shares acquired and, if this Warrant has not been fully exercised or converted and has
not expired, a new warrant of like tenor representing the Shares not so acquired (or otherwise surrendered to the Company in connection with conversion under Article 1.2 above). 

1.5 Replacement of Warrants. On receipt of evidence reasonably satisfactory to the Company of the loss, theft,
destruction or mutilation of this Warrant and, in the case of loss, theft or destruction, on delivery of an indemnity agreement reasonably satisfactory in form and amount to the Company or, in the case of mutilation, on surrender and cancellation of
this Warrant, the Company shall execute and deliver, in lieu of this Warrant, a new warrant of like tenor and amount. 
 1.6 Treatment of Warrant Upon Acquisition of Company. 

1.6.1 “Acquisition”. For the purpose of this Warrant, “Acquisition” means any sale,
assignment, transfer or other disposition of all or substantially all of the assets of the Company, or any reorganization, consolidation, merger, or sale of outstanding equity securities of the Company by the holders thereof, where the holders of
the Company’s outstanding voting equity securities as of immediately before the transaction beneficially own less than a majority of the outstanding voting equity securities of the surviving or successor entity as of immediately after the
transaction or, if such Company shareholders beneficially own a majority of the outstanding voting equity securities of the surviving or successor entity as of immediately after the transaction, such surviving or successor entity is not the Company;
provided, that “Acquisition” shall not include sales of its securities by the Company the primary purpose of which is to raise capital. 
 1.6.2 Treatment of Warrant at Acquisition. 
 A) Holder agrees that, in the
event of an Acquisition in which the sole consideration is cash and/or Marketable Securities, this Warrant shall terminate on and as of the closing of such Acquisition to the extent not previously exercised. The Company shall provide Holder with
written notice of any proposed Acquisition not later than ten (10) days prior to the closing thereof setting forth the material terms and conditions thereof, 

  
 2 

 
and shall provide Holder with copies of the draft transaction agreements and other documents in connection therewith and with such other information respecting such proposed Acquisition as may
reasonably be requested by Holder. Notwithstanding the foregoing, if Holder fails to formally exercise this Warrant in accordance with the provisions hereof after receiving notice of an Acquisition under this Article 1 .6.2(A), then (i) to the
extent the cash and/or Marketable Securities consideration per Share to be paid at the closing of such Acquisition exceeds the then-effective Warrant Price, this Warrant shall be deemed converted in accordance with the provisions of Article 1.2 as
of immediately prior to the closing of such Acquisition, or (ii) to the extent the cash and/or Marketable Securities consideration per Share to be paid at the closing of such Acquisition does not exceed the then-effective Warrant Price, this
Warrant shall terminate upon the consummation of such Acquisition. 
 B) Upon the closing of any Acquisition other than as
particularly described in subsection (A) above, the surviving or successor entity shall assume this Warrant and the obligations of the Company hereunder, and this Warrant shall, from and after such closing, be exercisable for the same class,
number and kind of securities, cash and other property as would have been paid for or in respect of the Shares issuable (as of immediately prior to such closing) upon exercise in full hereof as if such Shares had been issued and outstanding on and
as of such closing, at an aggregate Warrant Price equal to the aggregate Warrant Price in effect as of immediately prior to such closing; and subject to further adjustment thereafter from time to time in accordance with the provisions of this
Warrant. 
 C) As used in this Article 1 .6, “Marketable Securities” means securities meeting all of the following
requirements: (i) the issuer thereof is then subject to the reporting requirements of Section 13 or Section 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and is then current in its filing of
all required reports and other information under the Act and the Exchange Act; (ii) the class and series of shares or other security of the issuer that would be received by Holder in connection with the Acquisition were Holder to exercise or
convert this Warrant on or prior to the closing thereof is then traded on a national securities exchange or over-the-counter market, and (iii) Holder would not be restricted by contract or by applicable federal and state securities laws from
publicly re-selling, within six (6) months and one day following the closing of such Acquisition, all of the issuer’s shares and/or other securities that would be received by Holder in such Acquisition were Holder to exercise or convert
this Warrant in full on or prior to the closing of such Acquisition. 
 ARTICLE 2. ADJUSTMENTS TO THE SHARES. 

2.1 Stock Dividends, Splits, Etc. If the Company declares or pays a dividend on the outstanding shares of the Class
payable in additional shares of the Class or other securities, then upon exercise of this Warrant, for each Share acquired, Holder shall receive, without cost to Holder, the total number and kind of securities to which Holder would have been
entitled had Holder owned the Shares of record as of the date the dividend occurred. If the Company subdivides the outstanding shares of the Class by reclassification or otherwise into a greater number of shares, the number of Shares purchasable
hereunder shall be proportionately increased and the Warrant Price shall be proportionately decreased. If the outstanding shares of the Class are combined or consolidated, by reclassification or otherwise, into a lesser number of shares, the

  
 3 

 
Warrant Price shall be proportionately increased and the number of Shares shall be proportionately decreased. 

2.2 Reclassification, Exchange, Conversion or Substitution. Upon any reclassification, exchange, conversion,
substitution or similar event affecting the outstanding shares of the Class, Holder shall be entitled to receive, upon exercise or conversion of this Warrant, the number and kind of securities and property that Holder would have received for the
Shares if this Warrant had been exercised in full immediately before such reclassification, exchange, conversion, substitution or similar event, at an aggregate Warrant Price not exceeding the aggregate Warrant Price in effect as of immediately
prior thereto. The Company or its successor shall promptly issue to Holder a certificate pursuant to Article 26 hereof setting forth the number, class and series or other designation of such new securities or other property issuable upon exercise or
conversion of this Warrant as a result of such reclassification, exchange, conversion, substitution or similar event. The provisions of this Article 2.2 shall similarly apply to successive reclassifications, exchanges, conversions, substitutions,
and similar events. 
 2.3 Adjustments for Diluting Issuances. The number of Shares issuable upon
exercise or conversion of this Warrant shall be subject to adjustment from time to time in accordance with the provisions of that certain Antidilution Agreement of even date herewith between the Company and Holder. 

2.4 No Impairment. The Company shall not, by amendment of its Certificate of Incorporation or through a
reorganization, transfer of assets, consolidation, merger, dissolution, issue, or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms to be observed or performed under this
Warrant by the Company, but shall at all times in good faith assist in carrying out of all the provisions of this Article 2 and in taking all such action as may be necessary or appropriate to protect Holders rights under this Article against
impairment provided, however, that nothing in this Warrant shall prohibit the Company from taking any corporate action (including an amendment of its Certificate of Incorporation or a reorganization, transfer of assets, consolidation,
merger, dissolution, issue or sale of securities or any other voluntary action) if the Company receives the approval of its Board of Directors and shareholders required under its Certificate of Incorporation and applicable law as long as such action
does not adversely affect Holder in a different manner than all other holders of shares of the Class. 
 2.5
Fractional Shares. No fractional Share shall be issuable upon exercise or conversion of the Warrant and the number of Shares to be issued shall be rounded down to the nearest whole Share. If a fractional share interest arises upon any
exercise or conversion of the Warrant, the Company shall eliminate such fractional share interest by paying Holder the amount computed by multiplying the fractional interest by the fair market value (as determined pursuant to Article 1 .3 above) of
a full Share. 
 2.6 Certificate as to Adjustments. Upon each adjustment of the Warrant Price, Class
and/or number of Shares, the Company shall promptly notify Holder in writing, and, at the Company’s expense, promptly compute such adjustment, and furnish Holder with a certificate of its Chief Financial Officer setting forth such adjustment
and the facts upon which such adjustment is based. The Company shall, upon written request, furnish Holder a certificate setting forth the Warrant Price, Class 

  
 4 

 
and number of Shares in effect upon the date thereof and the series of adjustments leading to such Warrant Price, Class and number of Shares. 

2.7 Pay to Play Adjustments. Notwithstanding the definition of Class herein, if Pay to Play Provisions are at any
time during the term of this Warrant applied to the outstanding shares of the Class, then from and after such application, “Class” shall mean that class and series of the Company’s securities that a holder of outstanding shares of the
Class as of immediately prior to such application would have received or retained had such holder participated in the manner necessary to receive or retain the class and series of the Company’s securities having the relative rights, powers,
privileges and preferences more favorable to the holder. As used herein, “Pay to Play Provisions” means provisions set forth in the Company’s Certificate of Incorporation or elsewhere that require holders of the outstanding shares of
the Class to participate in a subsequent round of equity financing of the Company or lose all or a portion of the benefit of anti-dilution protection or any other right, power, privilege or preference applicable to such shares or have such shares
automatically convert to common stock or another class or series of Company capital stock. 
 2.8 No
Duplicative Adjustments. Notwithstanding anything in this Warrant to the contrary, in the event that any adjustment required in this Article 2 is otherwise effected by operation of the Company’s Certificate of Incorporation, such adjustment
shall not be effected pursuant to the provisions hereof. 
 ARTICLE 3. REPRESENTATIONS AND COVENANTS OF THE COMPANY.

 3.1 Representations and Warranties. The Company represents and warrants to, and agrees with, the Holder
as follows: 
 (a) The initial Warrant Price first set forth above is the fair market value of a share of the
Class as determined pursuant to the Company’s IRC Section 409A valuation as of March 31, 2011. 

(b) The Company shall at all times during the term of this Warrant keep reserved out of its authorized and unissued
capital stock a sufficient number of shares of the Class to permit exercise in full of this Warrant. All Shares which may be issued upon the exercise or conversion of this Warrant shall, upon issuance, be duly authorized, validly issued, fully paid
and non-assessable, and free of any liens and encumbrances except for restrictions on transfer provided for herein or under applicable federal and state securities laws. 

(c) The Company’s capitalization table attached hereto as Schedule 1 is true and complete as of the Issue
Date. 
 3.2 Notice of Certain Events. If the Company proposes at any time (a) to declare any
dividend or distribution upon the outstanding shares of the Class, whether in cash, property, stock, or other securities and whether or not a regular cash dividend; (b) to offer for subscription or sale pro rata to the holders of the
outstanding shares of the Class any additional shares of any class or series of the Company’s stock (other than pursuant to contractual pre-emptive rights); (c) to effect any event described in Article 2.2 above, (d) to effect an
Acquisition or to liquidate, dissolve or wind up; or (e) to consummate an IPO; then, in connection with each such event, the Company shall 

  
 5 

 
give Holder: (1) at least 10 days prior written notice of the date on which a record will be taken for such dividend, distribution, or subscription rights (and specifying the date on which
the holders of shares of the Class will be entitled thereto) or for determining rights to vote, if any, in respect of the matters referred to in (c) and (d) above; (2) in the case of the matters referred to in (c) and
(d) above at least 10 days prior written notice of the date when the same will take place (and specifying the date on which the holders of shares of the Class will be entitled to exchange their shares for the securities or other property
deliverable upon the occurrence of such event), and (3) in the case of the matter referred to in (e) above, at least ten (10) days written notice prior to the anticipated effective date of the registration statement. 

3.3 Registration Rights. The Company agrees that the Shares shall have the piggyback registration rights
(i.e., the right to participate in registrations initiated by other parties) and the S-3 demand registration rights pursuant to and as set forth in the Company’s Investor Rights Agreement or similar agreement (“Rights
Agreement”), on a pari passu basis with the investor parties thereto. The provisions set forth in the Rights Agreement relating to the above in effect as of the Issue Date may not be amended, modified or waived without the prior written
consent of Holder unless such amendment, modification or waiver affects the rights associated with the Shares in the same manner as such amendment, modification, or waiver affects the rights associated with all other Company shares held by investors
who are parties thereto. 
 3.4 No Shareholder Rights. Except as provided in this Warrant, Holder will
not have any rights as a shareholder of the Company until the exercise or conversion of this Warrant. 
 3.5
Certain Information. At all times prior to the IPO, the Company agrees to provide Holder at any time and from time to time with such information as Holder may reasonably request for purposes of Holder’s compliance with regulatory,
accounting and reporting requirements applicable to Holder. 
 3.6 Participation in Overallotment Option.
In the event that the Company consummates an IPO and the underwriters thereof exercise any overallotment, or “Green Shoe,” option granted by the Company to such underwriters in connection therewith, the Company agrees that Holder shall
have the right (but not the obligation), exercisable in its sole discretion, to sell to the underwriters, and the Company agrees that it shall cause the underwriters to purchase from Holder, for re-sale by such underwriters pursuant to the final
prospectus relating to the IPO, such number of Shares issued and issuable hereunder as shall equal a fraction, (i) the numerator of which shall equal the total number of Shares then issued and issuable hereunder, and (ii) the denominator
of which shall equal the sum of such numerator plus the aggregate total of all Company shares of the Class then beneficially and of record owned by all other securityholders of the Company, if any, participating in such sale to the underwriters in
satisfaction of such overallotment option, at a price per Share equal to the price paid by the underwriters to the Company as set forth in such final prospectus and otherwise on the same terms and conditions as applicable to such other
securityholders (if any) or, if there be none, to the Company under the underwriting agreement between the Company and such underwriters executed in connection with the IPO. 

  
 6 

 ARTICLE 4. REPRESENTATIONS, WARRANTIES OF THE HOLDER. The Holder represents and
warrants to the Company as follows: 
 4.1 Purchase for Own Account. This Warrant and the securities to
be acquired upon exercise of this Warrant by Holder will be acquired for investment for Holder’s account, not as a nominee or agent, and not with a view to the public resale or distribution within the meaning of the Act. Holder also represents
that it has not been formed for the specific purpose of acquiring this Warrant or the Shares. 
 4.2
Disclosure of Information. Holder has received or has had full access to all the information it considers necessary or appropriate to make an informed investment decision with respect to the acquisition of this Warrant and its underlying
securities. Holder further has had an opportunity to ask questions and receive answers from the Company regarding the terms and conditions of the offering of this Warrant and its underlying securities and to obtain additional information (to the
extent the Company possessed such information or could acquire it without unreasonable effort or expense) necessary to verify any information furnished to Holder or to which Holder has access. 

4.3 Investment Experience. Holder understands that the purchase of this Warrant and its underlying securities
involves substantial risk. Holder has experience as an investor in securities of companies in the development stage and acknowledges that Holder can bear the economic risk of such Holder’s investment in this Warrant and its underlying
securities and has such knowledge and experience in financial or business matters that Holder is capable of evaluating the merits and risks of its investment in this Warrant and its underlying securities and/or has a preexisting personal or business
relationship with the Company and certain of its officers, directors or controlling persons of a nature and duration that enables Holder to be aware of the character, business acumen and financial circumstances of such persons. 

4.4 Accredited Investor Status. Holder is an “accredited investor” within the meaning of Regulation D
promulgated under the Act. 
 4.5 The Act. Holder understands that this Warrant and the Shares issuable
upon exercise or conversion hereof have not been registered under the Act in reliance upon a specific exemption therefrom, which exemption depends upon, among other things, the bona fide nature of the Holder’s investment intent as expressed
herein. Holder understands that this Warrant and the Shares issued upon any exercise or conversion hereof must be held indefinitely unless subsequently registered under the Act and qualified under applicable state securities laws, or unless
exemption from such registration and qualification are otherwise available. 
 4.6 Market Stand-off.
Subject to Article 3.6 above, Holder hereby agrees to be subject to and bound by all of the obligations of the Rights Agreement, including the terms and conditions of the market stand-off agreement contained in Section 1.14 of the Rights
Agreement, in the same manner and to the same extent as the investor parties to the Rights Agreement who have piggyback and S-3 registration rights thereunder. 
 ARTICLE 5. MISCELLANEOUS. 

  
 7 

 5.1 Term: This Warrant is exercisable in whole or in part at any time
and from time to time on or before the earlier to occur (the “Expiration Date”) of (a) the tenth (10th) anniversary of the Issue Date hereof, and (b) as of immediately prior to the effectiveness of the Company’s
registration statement filed in connection with the IPO. 
 5.2 Legend. Each certificate representing
Shares issued upon any exercise or conversion hereof shall be imprinted with a legend in substantially the following form: 
 THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AND PURSUANT TO
THE PROVISIONS OF ARTICLE 5 OF THAT CERTAIN WARRANT TO PURCHASE STOCK ISSUED BY THE COMPANY TO SILICON VALLEY BANK DATED AS OF MAY 17, 2011, MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL REGISTERED UNDER
SAID ACT AND APPLICABLE STATE SECURITIES LAW OR, IN THE OPINION OF LEGAL COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE ISSUER OF THESE SECURITIES, SUCH OFFER, SALE OR TRANSFER, PLEDGE OR HYPOTHECATION IS EXEMPT FROM REGISTRATION. 

5.3 Compliance with Securities Laws on Transfer. This Warrant and the Shares issuable upon exercise of this
Warrant may not be transferred or assigned in whole or in part without compliance with applicable federal and state securities laws by the transferor and the transferee (including, without limitation, the delivery of investment representation
letters and legal opinions reasonably satisfactory to the Company, as reasonably requested by the Company). The Company shall not require Holder to provide an opinion of counsel if the transfer is to SVB Financial Group (Silicon Valley Bank’s
parent company) or any other affiliate of Holder, provided that such affiliate is an “accredited investor” as defined in Regulation D promulgated under the Act. 

5.4 Transfer Procedure. After receipt by Silicon Valley Bank (“Bank”) of the executed Warrant, Bank will
transfer all of this Warrant to SVB Financial Group, Holder’s parent company. Subject to the provisions of Article 5.3 and upon providing the Company with written notice, SVB Financial Group and any subsequent Holder may transfer all or part of
this Warrant or the Shares issuable upon exercise of this Warrant to any transferee, provided, however, in connection with any such transfer, SVB Financial Group or any subsequent Holder will give the Company notice of the portion of the Warrant
being transferred with the name, address and taxpayer identification number of the transferee and Holder will surrender this Warrant to the Company for reissuance to the transferee(s) (and Holder if applicable). The Company may refuse to transfer
this Warrant or the Shares to any person or entity that directly competes with the Company, unless, in either case, the stock of the Company is publicly traded. 

5.5 Notices. All notices and other communications from the Company to the Holder, or vice versa, shall be deemed
delivered and effective when given personally, or on the third (3) business day after being mailed by first-class registered or certified mail, postage prepaid, or on the first business day after transmission by facsimile or deposit with a
reliable overnight courier, fee prepaid, at such address as 

  
 8 

 
may have been furnished to the Company or Holder, as the case may be, in writing by the Company or such holder from time to time. All notices to Holder shall be addressed as follows until the
Company receives notice of a change of address in connection with a transfer or otherwise: 
 SVB Financial Group 

Attn: Treasury Department 
 3003 Tasman Drive, HA 200 
 Santa Clara, CA 95054 

Telephone: 408-654-7400 
 Facsimile: 408-496-2405 
 Notice to the Company shall be addressed
as follows until Holder receives notice of a change in address: 
 Jive Software, Inc. 

Attn: Chief Financial Officer 
 915 SW Stark Street, 4th Floor 
 Portland, OR 97205 

Telephone: 503-972-9001 
 Facsimile: 503-296-2168 
 5.6 Waiver. This Warrant and any
term hereof may be changed, waived, discharged or terminated only by an instrument in writing signed by the party against which enforcement of such change, waiver, discharge or termination is sought. 

5.7 Attorneys’ Fees. In the event of any dispute between the parties concerning the terms and provisions of
this Warrant, the party prevailing in such dispute shall be entitled to collect from the other party all costs incurred in such dispute, including reasonable attorneys’ fees and disbursements. 

5.8 Automatic Conversion upon Expiration. In the event that, upon the Expiration Date, the fair market value of
one Share (or other security issuable upon the exercise hereof) as determined in accordance with Article 1.3 above is greater than the Warrant Price in effect on such date, then this Warrant shall automatically be deemed on and as of such date to be
converted pursuant to Article 1.2 above as to all Shares (or such other securities) for which it shall not previously have been exercised or converted, and the Company shall promptly deliver a certificate representing the Shares (or such other
securities) issued upon such conversion to Holder. 
 5.9 Counterparts. This Warrant may be executed in
counterparts, all of which together shall constitute one and the same agreement. 
 5.10 Successors and
Assigns. The terms and conditions of this Warrant shall be binding upon, and shall inure to the benefit of, the respective successors and assigns of the parties. 

5.11 Governing Law. This Warrant shall be governed by and construed in accordance with the laws of the State of
California, without giving effect to its principles regarding conflicts of law. 

  
 9 

 [Remainder of page left blank intentionally; signature page follows] 

  
 10 

 IN WITNESS WHEREOF, the parties have executed this Warrant to Purchase Stock by their duly
authorized representatives as of the date first above written. 
  

			
	COMPANY
	
	JIVE SOFTWARE, INC.

			
		
	By:	 	 

			
		
	Name:	 	 Bryan LeBlanc

			
		 	(Print)

			
	Title:	 	 CFO

	
	HOLDER
	
	SILICON VALLEY BANK

			
		
	By:	 	 

			
		
	Name:	 	 [ILLEGIBLE]

			
		 	(Print)

			
	Title:	 	 SRM

  
 11 

 APPENDIX 1 
 NOTICE OF EXERCISE 
 1. Holder elects to purchase
                 shares of the Common Stock of
                                         pursuant
to the terms of the attached Warrant, and tenders payment of the purchase price of the shares in full. 
 [or]

 1. Holder elects to convert the attached Warrant into Shares/cash [strike one] in the manner specified in the
Warrant. This conversion is exercised for
                                         of the
Shares covered by the Warrant. 
 [Strike paragraph that does not apply.] 

2. Please issue a certificate or certificates representing the Shares in the name specified below: 

 

	
	  

	 Holders Name

	
	  

	
	  

	 (Address)

 3. By its execution below and for the benefit of the Company, Holder hereby
restates each of the representations and warranties in Article 4 of the Warrant as of the date hereof. 
  

			
	HOLDER:
	
	  

		
	By:	 	  

			
		
	Name:	 	  

			
		
	Title:	 	  

			
		
	(Date):	 	  

  
 122007 Stock Incentive Plan, as amended, and Form of Stock Option Agreement

 Exhibit 10.1 
 JIVE SOFTWARE, INC. 
 2007 STOCK INCENTIVE PLAN 

1. Purpose. The purpose of this 2007 Stock Incentive Plan (the “Plan”) is to enable Jive Software, Inc., a Delaware
corporation (the “Company”) to attract and retain the services of (i) selected employees, officers and directors of the Company or any parent or subsidiary of the Company and (ii) selected nonemployee agents, consultants,
advisers and independent contractors of the Company or any parent or subsidiary of the Company. For purposes of this Plan, a person is considered to be employed by or in the service of the Company if the person is employed by or in the service of
any entity (the “Employer”) that is either the Company or a parent or subsidiary of the Company. 
 2. Shares
Subject to the Plan. Subject to adjustment as provided below and in Section 9, the shares to be offered under the Plan shall consist of Common Stock of the Company, and the total number of shares of Common Stock that may be issued under the
Plan shall be 19,471,538 shares. If an option granted under the Plan expires, terminates or is canceled, the unissued shares subject to that option shall again be available under the Plan. If shares awarded as a bonus pursuant to Section 7 or
sold pursuant to Section 8 under the Plan are forfeited to or repurchased by the Company, the number of shares forfeited or repurchased shall again be available under the Plan. 

3. Effective Date and Duration of Plan. 
 3.1 Effective Date. The Plan became effective as of August 3, 2007 and was approved within 12 months of that date by the affirmative vote of the holders of a majority of the then
outstanding shares of capital stock entitled to vote, which vote was obtained by means of one or more written consents signed by holders having not less than the minimum number of votes that would have been necessary to approve the Plan at a
stockholders meeting. No option granted under the Plan became exercisable, and no shares were awarded as a bonus or sold under the Plan, before such stockholder approval was obtained. Subject to the foregoing, options may be granted at any time
after the effective date and before termination of the Plan, and shares may be awarded as bonuses or sold under the Plan at any time after stockholder approval and before termination of the Plan. 

3.2 Duration. The Plan shall continue in effect until the earlier of (a) August 3, 2017 or (b) such time as
all shares available for issuance under the Plan have been issued and all restrictions on the shares have lapsed. The Board of Directors may suspend or terminate the Plan at any time except with respect to options and shares subject to restrictions
then outstanding under the Plan. Termination shall not affect any outstanding options, any right of the Company to repurchase shares or the forfeitability of shares issued under the Plan. 

4. Administration. 
 4.1 Board of Directors. The Plan shall be administered by the Board of Directors of the Company, which shall determine and designate the individuals to whom awards

 
shall be made, the amount of the awards and the other terms and conditions of the awards. Subject to the provisions of the Plan, the Board of Directors may adopt and amend rules and regulations
relating to administration of the Plan, advance the lapse of any waiting period, accelerate any exercise date, waive or modify any restriction applicable to shares (except those restrictions imposed by law) and make all other determinations in the
judgment of the Board of Directors necessary or desirable for the administration of the Plan. The interpretation and construction of the provisions of the Plan and related agreements by the Board of Directors shall be final and conclusive. The Board
of Directors may correct any defect or supply any omission or reconcile any inconsistency in the Plan or in any related agreement in the manner and to the extent it deems expedient to carry the Plan into effect, and the Board of Directors shall be
the sole and final judge of such expediency. 
 4.2 Committee. The Board of Directors may delegate to any
committee of the Board of Directors (the “Committee”) any or all authority for administration of the Plan. If authority is delegated to the Committee, all references to the Board of Directors in the Plan shall mean and relate to the
Committee, except (i) as otherwise provided by the Board of Directors and (ii) that only the Board of Directors may amend or terminate the Plan as provided in Sections 3 and 10. 

5. Types of Awards, Eligibility, Limitations. The Board of Directors may, from time to time, take the following actions,
separately or in combination, under the Plan: (i) grant Incentive Stock Options, as defined in Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”), as provided in Sections 6.1 and 6.2; (ii) grant
options other than Incentive Stock Options (“Non-Statutory Stock Options”) as provided in Sections 6.1 and 6.3; (iii) award stock bonuses as provided in Section 7; and (iv) sell shares subject to restrictions as
provided in Section 8. Awards may be made to employees, including employees who are officers or directors, and to other individuals described in Section 1 selected by the Board of Directors; provided, however, that only employees of the
Company or any parent or subsidiary of the Company (as defined in subsections 424(e) and 424(f) of the Code) are eligible to receive Incentive Stock Options under the Plan. The Board of Directors shall select the individuals to whom awards shall be
made and shall specify the action taken with respect to each individual to whom an award is made. At the discretion of the Board of Directors, an individual may be given an election to surrender an award in exchange for the grant of a new award.

 6. Option Grants. 
 6.1 General Rules Relating to Options. 
 6.1-1 Terms of
Grant. The Board of Directors may grant options under the Plan. With respect to each option grant, the Board of Directors shall determine the number of shares subject to the option, the exercise price, the period of the option, the time or times
at which the option may be exercised and whether the option is an Incentive Stock Option or a Non-Statutory Stock Option. At the time of the grant of an option or at any time thereafter, the Board of Directors may provide that an optionee who
exercised an option with Common Stock of the Company shall automatically receive a new option to purchase additional shares equal to the number of shares surrendered and may specify the terms and conditions of such new options. 

  
 2 

 6.1-2 Exercise of Options. Except as provided in Section 6.1-4 or as determined
by the Board of Directors, no option granted under the Plan may be exercised unless at the time of exercise the optionee is employed by or in the service of the Company and shall have been so employed or provided such service continuously since the
date the option was granted. Except as provided in Sections 6.1-4 and 9, options granted under the Plan may be exercised from time to time over the period stated in each option in amounts and at times prescribed by the Board of Directors,
provided that options may not be exercised for fractional shares. Unless otherwise determined by the Board of Directors, if an optionee does not exercise an option in any one year for the full number of shares to which the optionee is entitled in
that year, the optionee’s rights shall be cumulative and the optionee may purchase those shares in any subsequent year during the term of the option. 
 6.1-3 Nontransferability. Each option granted under the Plan by its terms (i) shall be nonassignable and nontransferable by the optionee, either voluntarily or by operation of law, except by
will or by the laws of descent and distribution of the state or country of the optionee’s domicile at the time of death, and (ii) during the optionee’s lifetime, shall be exercisable only by the optionee; provided, however, that the
Board of Directors may permit a Non-Statutory Stock Option to be transferable by gift or domestic relations order to a family member of the optionee. For this purpose, the term “family member” includes any child, stepchild, grandchild,
parent, stepparent, grandparent, spouse, former spouse, sibling, niece, nephew, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law, including adoptive relationships, and any trust in which these persons have
more than 50% of the beneficial interest. 
 6.1-4 Termination of Employment or Service. 

(a) General Rule. Unless otherwise determined by the Board of Directors, if an optionee’s employment or service with the
Company terminates for any reason other than because of total disability or death as provided in Sections 6.1-4(b) and (c), his or her option may be exercised at any time before the expiration date of the option or the expiration of 30 days
after the date of termination, whichever is the shorter period, but only if and to the extent the optionee was entitled to exercise the option at the date of termination; provided, however, that the Board of Directors may not provide for a
post-termination exercise period that ends before the earlier of (i) the expiration of 30 days after the date of termination or (ii) the expiration date of the option. 

(b) Termination Because of Total Disability. Unless otherwise determined by the Board of Directors, if an optionee’s
employment or service with the Company terminates because of total disability, his or her option may be exercised at any time before the expiration date of the option or before the date 12 months after the date of termination, whichever is the
shorter period, but only if and to the extent the optionee was entitled to exercise the option at the date of termination; provided, however, that the Board of Directors may not provide for a post-termination exercise period that ends before the
earlier of (i) the expiration of 6 months after the date of termination or (ii) the expiration date of the option. The term “total disability” means a medically determinable mental or physical impairment that is expected to
result in death or has lasted or is expected to last for a continuous period of 12 months or more and that, in the opinion of the Company and two independent physicians, causes the optionee to

  
 3 

 
be unable to perform his or her duties as an employee, director, officer or consultant of the Employer and unable to be engaged in any substantial gainful activity. Total disability shall be
deemed to have occurred on the first day after the two independent physicians have furnished their written opinion of total disability to the Company and the Company has reached an opinion of total disability. 

(c) Termination Because of Death. Unless otherwise determined by the Board of Directors, if an optionee dies while employed by or
providing service to the Company, his or her option may be exercised at any time before the expiration date of the option or before the date 12 months after the date of death, whichever is the shorter period, but only if and to the extent the
optionee was entitled to exercise the option at the date of death and only by the person or persons to whom the optionee’s rights under the option shall pass by the optionee’s will or by the laws of descent and distribution of the state or
country of domicile at the time of death; provided, however, that the Board of Directors may not provide for a post-termination exercise period that ends before the earlier of (i) the expiration of 6 months after the date of termination or
(ii) the expiration date of the option. 
 (d) Amendment of Exercise Period Applicable to Termination. The Board of
Directors may at any time extend the 30-day and 12-month exercise periods any length of time not longer than the original expiration date of the option. The Board of Directors may at any time increase the portion of an option that is exercisable,
subject to terms and conditions determined by the Board of Directors. 
 (e) Failure to Exercise Option. To the extent
that the option of any deceased optionee or any optionee whose employment or service terminates is not exercised within the applicable period, all further rights to purchase shares pursuant to the option shall cease and terminate. 

(f) Leave of Absence. Absence on leave approved by the Employer or on account of illness or disability shall not be deemed a
termination or interruption of employment or service. Unless otherwise determined by the Board of Directors, vesting of options shall continue during a medical, family or military leave of absence, whether paid or unpaid, and vesting of options
shall be suspended during any other unpaid leave of absence. 
 6.1-5 Purchase of Shares. 

(a) Notice of Exercise. Unless the Board of Directors determines otherwise, shares may be acquired pursuant to an option granted
under the Plan only upon the Company’s receipt of written notice from the optionee of the optionee’s binding commitment to purchase shares, specifying the number of shares the optionee desires to purchase under the option and the date on
which the optionee agrees to complete the transaction, and, if required to comply with the Securities Act of 1933, containing a representation that it is the optionee’s intention to acquire the shares for investment and not with a view to
distribution. 
 (b) Payment. Unless the Board of Directors determines otherwise, on or before the date specified for
completion of the purchase of shares pursuant to an option exercise, the optionee must pay the Company the full purchase price of those shares in 

  
 4 

 
cash or by check or, with the consent of the Board of Directors, in whole or in part, in Common Stock of the Company valued at fair market value, restricted stock or other contingent awards
denominated in either stock or cash, promissory notes and other forms of consideration. Unless otherwise determined by the Board of Directors, any Common Stock provided in payment of the purchase price must have been previously acquired and held by
the optionee for at least six months. The fair market value of Common Stock provided in payment of the purchase price shall be the closing price of the Common Stock last reported before the time payment in Common Stock is made or, if earlier,
committed to be made, if the Common Stock is publicly traded, or another value of the Common Stock as specified by the Board of Directors. No shares shall be issued until full payment for the shares has been made, including all amounts owed for tax
withholding. With the consent of the Board of Directors, an optionee may request the Company to apply automatically the shares to be received upon the exercise of a portion of a stock option (even though stock certificates have not yet been issued)
to satisfy the purchase price for additional portions of the option. 
 (c) Tax Withholding. Each optionee who has
exercised an option shall, immediately upon notification of the amount due, if any, pay to the Company in cash or by check amounts necessary to satisfy any applicable federal, state and local tax withholding requirements. If additional withholding
is or becomes required (as a result of exercise of an option or as a result of disposition of shares acquired pursuant to exercise of an option) beyond any amount deposited before delivery of the certificates, the optionee shall pay such amount, in
cash or by check, to the Company on demand. If the optionee fails to pay the amount demanded, the Company or the Employer may withhold that amount from other amounts payable to the optionee, including salary, subject to applicable law. With the
consent of the Board of Directors, an optionee may satisfy this obligation, in whole or in part, by instructing the Company to withhold from the shares to be issued upon exercise or by delivering to the Company other shares of Common Stock;
provided, however, that the number of shares so withheld or delivered shall not exceed the minimum amount necessary to satisfy the required withholding obligation. 
 (d) Reduction of Reserved Shares. Upon the exercise of an option, the number of shares reserved for issuance under the Plan shall be reduced by the number of shares issued upon exercise of the
option (less the number of any shares surrendered in payment for the exercise price or withheld to satisfy withholding requirements). 
 6.1-6 Limitations on Grants to Non-Exempt Employees. Unless otherwise determined by the Board of Directors, if an employee of the Company or any parent or subsidiary of the Company is a non-exempt
employee subject to the overtime compensation provisions of Section 7 of the Fair Labor Standards Act (the “FLSA”), any option granted to that employee shall be subject to the following restrictions: (i) the option price shall be
at least 85 percent of the fair market value, as described in Section 6.2-4, of the Common Stock subject to the option on the date it is granted; and (ii) the option shall not be exercisable until at least six months after the date it
is granted; provided, however, that this six-month restriction on exercisability will cease to apply if the employee dies, becomes disabled or retires, there is a change in ownership of the Company, or in other circumstances permitted by regulation,
all as prescribed in Section 7(e)(8)(B) of the FLSA. 

  
 5 

 6.2 Incentive Stock Options. Incentive Stock Options shall be subject to the
following additional terms and conditions: 
 6.2-1 Limitation on Amount of Grants. If the aggregate fair market value
of stock (determined as of the date the option is granted) for which Incentive Stock Options granted under this Plan (and any other stock incentive plan of the Company or its parent or subsidiary corporations, as defined in subsections 424(e) and
424(f) of the Code) are exercisable for the first time by an employee during any calendar year exceeds $100,000, the portion of the option or options not exceeding $100,000, to the extent of whole shares, will be treated as an Incentive Stock Option
and the remaining portion of the option or options will be treated as a Non-Statutory Stock Option. The preceding sentence will be applied by taking options into account in the order in which they were granted. If, under the $100,000 limitation, a
portion of an option is treated as an Incentive Stock Option and the remaining portion of the option is treated as a Non-Statutory Stock Option, unless the optionee designates otherwise at the time of exercise, the optionee’s exercise of all or
a portion of the option will be treated as the exercise of the Incentive Stock Option portion of the option to the full extent permitted under the $100,000 limitation. If an optionee exercises an option that is treated as in part an Incentive Stock
Option and in part a Non-Statutory Stock Option, the Company will designate the portion of the stock acquired pursuant to the exercise of the Incentive Stock Option portion as Incentive Stock Option stock by issuing a separate certificate for that
portion of the stock and identifying the certificate as Incentive Stock Option stock in its stock records. 
 6.2-2
Limitations on Grants to 10 Percent Stockholders. An Incentive Stock Option may be granted under the Plan to an employee possessing more than 10 percent of the total combined voting power of all classes of stock of the Company or any
parent or subsidiary (as defined in subsections 424(e) and 424(f) of the Code) only if the option price is at least 110 percent of the fair market value, as described in Section 6.2-4, of the Common Stock subject to the option on the date it is
granted and the option by its terms is not exercisable after the expiration of five years from the date it is granted. 
 6.2-3
Duration of Options. Subject to Sections 6.1-2, 6.1-4 and 6.2-2, Incentive Stock Options granted under the Plan shall continue in effect for the period fixed by the Board of Directors, except that by its terms no Incentive Stock Option
shall be exercisable after the expiration of 10 years from the date it is granted. 
 6.2-4 Option Price. The option
price per share shall be determined by the Board of Directors at the time of grant. Except as provided in Section 6.2-2, the option price shall not be less than 100 percent of the fair market value of the Common Stock covered by the Incentive
Stock Option at the date the option is granted. The fair market value shall be the closing price of the Common Stock last reported before the time the option is granted, if the stock is publicly traded, or another value of the Common Stock as
specified by the Board of Directors. 
 6.2-5 Limitation on Time of Grant. No Incentive Stock Option shall be granted on
or after the tenth anniversary of the last action by the Board of Directors adopting the Plan or approving an increase in the number of shares available for issuance under the Plan, which action was subsequently approved within 12 months by the
stockholders. 

  
 6 

 6.2-6 Early Dispositions. If within two years after an Incentive Stock Option is
granted or within 12 months after an Incentive Stock Option is exercised, the optionee sells or otherwise disposes of Common Stock acquired on exercise of the Option, the optionee shall within 30 days of the sale or disposition notify the Company in
writing of (i) the date of the sale or disposition, (ii) the amount realized on the sale or disposition and (iii) the nature of the disposition (e.g., sale, gift, etc.). 

6.3 Non-Statutory Stock Options. Non-Statutory Stock Options shall be subject to the following terms and conditions, in
addition to those set forth in Section 6.1 above: 
 6.3-1 Option Price. The option price for Non-Statutory Stock
Options shall be determined by the Board of Directors at the time of grant and may be any amount determined by the Board of Directors. 
 6.3-2 Duration of Options. Subject to Sections 6.1-2 and 6.1-4, Non-Statutory Stock Options granted under the Plan shall continue in effect for the period fixed by the Board of Directors, except
that by its terms no Non-Statutory Stock Option shall be exercisable after the expiration of 10 years from the date it is granted. 
 7. Stock Bonuses. The Board of Directors may award shares under the Plan as stock bonuses. Shares awarded as a bonus shall be subject to the terms, conditions and restrictions determined by the
Board of Directors. The restrictions may include restrictions concerning transferability and forfeiture of the shares awarded, together with any other restrictions determined by the Board of Directors. The Board of Directors may require the
recipient to sign an agreement as a condition of the award, but may not require the recipient to pay any monetary consideration other than amounts necessary to satisfy tax withholding requirements. The agreement may contain any terms, conditions,
restrictions, representations and warranties required by the Board of Directors; provided, however, that the right to acquire the shares shall be nonassignable and nontransferable by the prospective recipient of the shares, either voluntarily or by
operation of law, except by will or by the laws of descent and distribution of the state or country of such prospective recipient’s domicile at the time of death. The certificates representing the shares awarded shall bear any legends required
by the Board of Directors. The Company may require any recipient of a stock bonus to pay to the Company in cash or by check upon demand amounts necessary to satisfy any applicable federal, state or local tax withholding requirements. If the
recipient fails to pay the amount demanded, the Company or the Employer may withhold that amount from other amounts payable to the recipient, including salary, subject to applicable law. With the consent of the Board of Directors, a recipient may
satisfy this obligation, in whole or in part, by instructing the Company to withhold from any shares to be issued or by delivering to the Company other shares of Common Stock; provided, however, that the number of shares so withheld or delivered
shall not exceed the minimum amount necessary to satisfy the required withholding obligation. Upon the issuance of a stock bonus, the number of shares reserved for issuance under the Plan shall be reduced by the number of shares issued, less the
number of shares withheld or delivered to satisfy withholding obligations. 
 8. Restricted Stock. The Board of Directors
may issue shares under the Plan for any consideration (including promissory notes and services) determined by the Board of 

  
 7 

 
Directors. Shares issued under the Plan shall be subject to the terms, conditions and restrictions determined by the Board of Directors. The restrictions may include restrictions concerning
transferability, repurchase by the Company and forfeiture of the shares issued, together with any other restrictions determined by the Board of Directors. All Common Stock issued pursuant to this Section 8 shall be subject to a purchase
agreement, which shall be executed by the Company and the prospective purchaser of the shares before the delivery of certificates representing the shares to the purchaser. The purchase agreement may contain any terms, conditions, restrictions,
representations and warranties required by the Board of Directors; provided, however, that the right to purchase the shares shall be nonassignable and nontransferable by the prospective recipient of the shares, either voluntarily or by operation of
law, except by will or by the laws of descent and distribution of the state or country of such prospective recipient’s domicile at the time of death. The certificates representing the shares shall bear any legends required by the Board of
Directors. The Company may require any purchaser of restricted stock to pay to the Company in cash or by check upon demand amounts necessary to satisfy any applicable federal, state or local tax withholding requirements. If the purchaser fails to
pay the amount demanded, the Company or the Employer may withhold that amount from other amounts payable to the purchaser, including salary, subject to applicable law. With the consent of the Board of Directors, a purchaser may satisfy this
obligation, in whole or in part, by instructing the Company to withhold from any shares to be issued or by delivering to the Company other shares of Common Stock; provided, however, that the number of shares so withheld or delivered shall not exceed
the minimum amount necessary to satisfy the required withholding obligation. Upon the issuance of restricted stock, the number of shares reserved for issuance under the Plan shall be reduced by the number of shares issued, less the number of shares
withheld or delivered to satisfy withholding obligations. 
 9. Changes in Capital Structure. 

9.1 Stock Splits, Stock Dividends. If the outstanding Common Stock of the Company is hereafter increased or decreased or
changed into or exchanged for a different number or kind of shares or other securities of the Company by reason of any stock split, combination of shares, dividend payable in shares, recapitalization or reclassification, appropriate adjustment shall
be made by the Board of Directors in the number and kind of shares available for grants under the Plan and in all other share amounts set forth in the Plan. In addition, the Board of Directors shall make appropriate adjustment in (a) the number
and kind of shares as to which outstanding options, or portions thereof then unexercised, shall be exercisable, and (b) the option price per share of outstanding options, so that the optionee’s proportionate interest before and after the
occurrence of the event is maintained. Notwithstanding the foregoing, the Board of Directors shall have no obligation to effect any adjustment that would or might result in the issuance of fractional shares, and any fractional shares resulting from
any adjustment may be disregarded or provided for in any manner determined by the Board of Directors. Any such adjustments made by the Board of Directors shall be conclusive. 
 9.2 Mergers, Reorganizations, Etc. In the event of a merger, consolidation, plan of exchange, acquisition of property or stock, split-up, split-off, spin-off, reorganization or liquidation
to which the Company is a party or any sale, lease, exchange or other transfer (in one transaction or a series of related transactions) of all, or substantially all, of the assets of the Company (each, a “Transaction”), the Board of
Directors shall, in its sole discretion and to the 

  
 8 

 
extent possible under the structure of the Transaction, select one of the following alternatives for treating outstanding options under the Plan: 

9.2-1 Outstanding options shall remain in effect in accordance with their terms. 

9.2-2 Outstanding options shall be converted into options to purchase stock in one or more of the corporations, including the Company,
that are the surviving or acquiring corporations in the Transaction. The amount, type of securities subject thereto and exercise price of the converted options shall be determined by the Board of Directors of the Company, taking into account the
relative values of the companies involved in the Transaction and the exchange rate, if any, used in determining shares of the surviving corporation(s) to be held by holders of shares of the Company following the Transaction. Unless otherwise
determined by the Board of Directors, the converted options shall be vested only to the extent that the vesting requirements relating to options granted hereunder have been satisfied. 

9.2-3 The Board of Directors shall provide a period of 30 days or less before the completion of the Transaction during which outstanding
options may be exercised to the extent then exercisable, and upon the expiration of that period, all unexercised options shall immediately terminate. The Board of Directors may, in its sole discretion, accelerate the exercisability of options so
that they are exercisable in full during that period. 
 9.3 Dissolution of the Company. In the event of the
dissolution of the Company, options shall be treated in accordance with Section 9.2-3. 
 9.4 Rights Issued by
Another Corporation. The Board of Directors may also grant options and stock bonuses and issue restricted stock under the Plan with terms, conditions and provisions that vary from those specified in the Plan, provided that any such awards
are granted in substitution for, or in connection with the assumption of, existing options, stock bonuses and restricted stock granted, awarded or issued by another corporation and assumed or otherwise agreed to be provided for by the Company
pursuant to or by reason of a Transaction. 
 10. Amendment of the Plan. The Board of Directors may at any time modify or
amend the Plan in any respect. Except as provided in Section 9, however, no change in an award already granted shall be made without the written consent of the holder of the award if the change would adversely affect the holder. 

11. Approvals. The Company’s obligations under the Plan are subject to the approval of state and federal authorities or
agencies with jurisdiction in the matter. The Company will use its best efforts to take steps required by state or federal law or applicable regulations, including rules and regulations of the Securities and Exchange Commission and any stock
exchange on which the Company’s shares may then be listed, in connection with the grants under the Plan. The foregoing notwithstanding, the Company shall not be obligated to issue or deliver Common Stock under the Plan if such issuance or
delivery would violate state or federal securities laws. 
 12. Employment and Service Rights. Nothing in the Plan or any
award pursuant to the Plan shall (i) confer upon any employee any right to be continued in the employment of an 

  
 9 

 
Employer or interfere in any way with the Employer’s right to terminate the employee’s employment at will at any time, for any reason, with or without cause, or to decrease the
employee’s compensation or benefits, or (ii) confer upon any person engaged by an Employer any right to be retained or employed by the Employer or to the continuation, extension, renewal or modification of any compensation, contract or
arrangement with or by the Employer. 
 13. Rights as a Stockholder. The recipient of any award under the Plan shall have
no rights as a stockholder with respect to any shares of Common Stock until the date the recipient becomes the holder of record of those shares. Except as otherwise expressly provided in the Plan, no adjustment shall be made for dividends or other
rights for which the record date occurs before the date the recipient becomes the holder of record. 
 Adopted by the Board of Directors and
Stockholders: August 3, 2007 
 Amended: April 17, 2009 (to increase total number of shares in Section 2 from 6,131,606 to
8,127,593 and to make certain revisions required pursuant to subdivision (o) of Section 25102 of the California Corporations Code) 

Amended: May 19, 2009 (to increase total number of shares in Section 2 from 8,127,593 to 8,327,593) 

Amended: July 29, 2009 (to increase total number of shares in Section 2 from 8,327,593 to 8,477,593) 

Amended: September 2, 2009 (to increase total number of shares in Section 2 from 8,477,593 to 9,003,463) 

Amended: October 13, 2009 (to increase total number of shares in Section 2 from 9,003,463 to 10,547,476) 

Amended: March 11, 2010 (to increase total number of shares in Section 2 from 10,547,476 to 11,547,476) 

Amended: June 3, 2010 (to increase total number of shares in Section 2 from 11,547,476 to 16,925,750) 

Amended: July 19, 2010 (to increase total number of shares in Section 2 from 16,925,750 to 17,675,750) 

Amended: November 5, 2010 (to increase total number of shares in Section 2 from 17,675,750 to 18,425,750) 

Amended: February 17, 2011 (to increase total number of shares in Section 2 from 18,425,750 to 18,775,750) 

Amended: March 16, 2011 (to increase total number of shares in Section 2 from 18,775,750 to 19,290,750) 

  
 10 

 Amended: June 7, 2011 (to increase the total number of shares in Section 2 from 19,290,750 to
19,471,538) 

  
 11 

 Jive Software, Inc. 

Incentive Stock Option Agreement 
 This Incentive Stock Option Agreement is between Jive Software, Inc., a Delaware corporation (the “Company”), and the Optionee (the “Optionee”), pursuant to the Company’s
2007 Stock Incentive Plan (the “Plan”). The Company and the Optionee agree as follows: 
 1. Time of Exercise of
Option. 
 1.1 Vesting Schedule. Until it expires or is terminated as provided in Sections 2, 7 or 8 of
this Exhibit A, the Option may be exercised from time to time to purchase whole shares as to which it has become exercisable. The Option shall become exercisable for 25% of the shares on the first anniversary of the Vesting Reference Date and
for 1/48th of the shares at the end of each one-month period thereafter, so that the Option will be fully exercisable on the fourth anniversary of the Vesting Reference Date. 
 1.2 Acceleration of Vesting. Notwithstanding Section 1.1, the vesting and exercisability of this Option shall be accelerated by fifty percent (50%) of the then unvested portion of this
Option if within one year following a Change in Control (as defined below) (a) the employment of the Optionee is terminated by the Company without Cause (as defined below), or (b) the employment of the Optionee is terminated by the
Optionee with Good Reason (as defined below). 
 1.3 Change in Control. For purposes of this Agreement, “Change in
Control” shall mean the occurrence of any of the following events: 
 1.3(a) The approval by the
shareholders of the Company of: 
 1.3(a)(1) any consolidation, merger or plan of share exchange involving the
Company (a “Merger”) as a result of which the holders of outstanding securities of the Company ordinarily having the right to vote for the election of directors (“Voting Securities”) immediately prior to the Merger do not
continue to hold at least 50% of the combined voting power of the outstanding Voting Securities of the surviving or continuing corporation immediately after the Merger, disregarding any Voting Securities issued or retained by such holders in respect
of securities of any other party to the Merger; 
 1.3(a)(2) any sale, lease, exchange or other transfer (in one
transaction or a series of related transactions) of all, or substantially all, the assets of the Company; or 

1.3(a)(3) the adoption of any plan or proposal for the liquidation or dissolution of the Company; 

1.3(b) At any time during a period of two consecutive years, individuals who at the beginning of such period constituted
the Board of Directors 

  
 1 

 
of the Company (“Incumbent Directors”) shall cease for any reason to constitute at least a majority thereof; provided, however, that the term “Incumbent Director” shall also
include each new director elected during such two-year period whose nomination or election was approved by two-thirds of the Incumbent Directors then in office; or 

1.3(c) Any “person” or “group” (within the meaning of Sections 13(d) and 14(d)(2) of the Securities
Exchange Act of 1934, as amended (the “Act”)) shall, as a result of a tender or exchange offer, open market purchases or privately negotiated purchases from anyone other than the Company, have become the beneficial owner (within the
meaning of Rule 13d-3 under the Act), directly or indirectly, of Voting Securities representing twenty percent (20%) or more of the combined voting power of the then outstanding Voting Securities. 

1.4 Cause. For purposes of this Agreement, termination of the Optionee’s employment for “Cause” shall mean
termination upon (a) the willful and continued failure by the Optionee to perform substantially the Optionee’s reasonably assigned duties with the Employer (other than any such failure resulting from the Optionee’s incapacity due to
physical or mental illness) after a demand for substantial performance is delivered to the Optionee by the Employer which specifically identifies the manner in which the Employer believes that the Optionee has not substantially performed the
Optionee’s duties or (b) the willful engaging by the Optionee in illegal conduct which is materially and demonstrably injurious to the Company or the Employer. No act, or failure to act, on the Optionee’s part shall be considered
“willful” if the Optionee reasonably believed that the Optionee’s action or omission was in, or not opposed to, the best interests of the Company and the Employer. 

1.5 Good Reason. For purposes of this Agreement, termination of the Optionee’s employment for “Good Reason” shall
mean termination upon: 
 1.5(a) the assignment to the Optionee of a different title, job or responsibilities
that results in a decrease in the level of responsibility of the Optionee with respect to the surviving company after the Change in Control when compared to the Optionee’ s level of responsibility for the Employer prior to the Change in
Control; provided that Good Reason shall not exist if the Optionee continues to have the same or a greater general level of responsibility for former Company operations after the Change in Control as the Optionee had prior to the Change in Control
even if the former Company operations are a subsidiary or division of the surviving company; 
 1.5(b) a
reduction by the Company or the surviving company in the Optionee’s base pay as in effect immediately prior to the Change in Control; 
 1.5(c) a significant reduction by the Company or the surviving company in total benefits available to the Optionee under cash incentive, stock incentive and other employee benefit plans after the Change
in Control compared to the total package of such benefits as in effect prior to the Change in Control; or 

  
 2 

 1.5(d) The Company or the surviving company requiring the Optionee to be based more than 50
miles from where the Optionee’s office is located immediately prior to the Change in Control except for required travel on company business to an extent substantially consistent with the business travel obligations which the Optionee undertook
on behalf of the Company prior to the Change in Control. 
 2. Termination of Employment or Service. 

2.1 General Rule. Except as provided in this Section 2, the Option may not be exercised unless at the time of exercise the
Optionee is employed by or in the service of the Company and shall have been so employed or provided such service continuously since the Grant Date. For purposes of this Exhibit A, the Optionee is considered to be employed by or in the service of
the Company if the Optionee is employed by or in the service of the Company or any parent or subsidiary of the Company (an “Employer”). 
 2.2 Termination Generally. If the Optionee’s employment or service with the Company terminates for any reason other than because of total disability or death as provided in Sections 2.3 or
2.4, the Option may be exercised at any time before the Expiration Date or the expiration of 30 days after the date of termination, whichever is the shorter period, but only if and to the extent the Optionee was entitled to exercise the Option
at the date of termination. 
 2.3 Termination Because of Total Disability. If the Optionee’s employment or service
with the Company terminates because of total disability, the Option may be exercised at any time before the Expiration Date or before the date 12 months after the date of termination, whichever is the shorter period, but only if and to the
extent the Optionee was entitled to exercise the Option at the date of termination. The term “total disability” means a medically determinable mental or physical impairment that is expected to result in death or has lasted or is
expected to last for a continuous period of 12 months or more and that, in the opinion of the Company and two independent physicians, causes the Optionee to be unable to perform duties as an employee of the Employer and unable to be engaged in
any substantial gainful activity. Total disability shall be deemed to have occurred on the first day after the two independent physicians have furnished their written opinion of total disability to the Company and the Company has reached an opinion
of total disability. 
 2.4 Termination Because of Death. If the Optionee dies while employed by or in the service of the
Company, the Option may be exercised at any time before the Expiration Date or before the date 12 months after the date of death, whichever is the shorter period, but only if and to the extent the Optionee was entitled to exercise the Option at
the date of death and only by the person or persons to whom the Optionee’s rights under the Option shall pass by the Optionee’s will or by the laws of descent and distribution of the state or country of domicile at the time of death.

 2.5 Leave of Absence. Absence on leave approved by the Employer or on account of illness or disability shall not be
deemed a termination or interruption of 

  
 3 

 
employment or service. Vesting of the Option shall continue during a medical, family or military leave of absence, whether paid or unpaid, and vesting of the Option shall be suspended during any
other unpaid leave of absence. 
 2.6 Failure to Exercise Option. To the extent that following termination of employment
or service, the Option is not exercised within the applicable periods described above, all further rights to purchase shares pursuant to the Option shall cease and terminate. 

3. Purchase of Shares.  
 3.1 Notice of Exercise. The Option may be exercised only by notice in writing from the Optionee to the Company of the Optionee’s binding commitment to purchase shares, specifying the number of
shares the Optionee desires to purchase under the Option and the date on which the Optionee agrees to complete the transaction, which may not be more than 30 days after delivery of the notice, and, if required to comply with the Securities Act
of 1933, containing a representation that it is the Optionee’s intention to acquire the shares for investment and not with a view to distribution. 
 3.2 Payment. On or before the date specified for completion of the purchase, the Optionee must pay the Company the full purchase price of those shares in cash or by check, or, if approved by the
Board of Directors in its sole discretion, in whole or in part in Common Stock of the Company valued at fair market value provided such Common Stock has been previously acquired and held by the Optionee for at least six months. The fair market value
of Common Stock provided in payment of the purchase price shall be the closing price of the Common Stock last reported before the time payment in Common Stock is made or, if earlier, committed to be made, if the Common Stock is publicly traded, or
another value of the Common Stock as specified by the Company. No shares shall be issued until full payment for the shares has been made, including all amounts owed for tax withholding. 

3.3 Tax Withholding. The Optionee shall, immediately upon notification of the amount due, if any, pay to the Company in cash or by
check amounts necessary to satisfy any applicable federal, state and local tax withholding requirements. If additional withholding is or becomes required (as a result of exercise of the Option or as a result of disposition of shares acquired
pursuant to exercise of the Option) beyond any amount deposited before delivery of the certificates, the Optionee shall pay such amount to the Company, in cash or by check, on demand. If the Optionee fails to pay the amount demanded, the Company or
the Employer may withhold that amount from other amounts payable to the Optionee, including salary, subject to applicable law. With the consent of the Board of Directors, Optionee may satisfy this obligation, in whole or in part, by instructing the
Company to withhold from the shares to be issued upon exercise or by delivering to the Company other shares of Common Stock; provided, however, that the number of shares so withheld or delivered shall not exceed the minimum amount necessary to
satisfy the required withholding obligation. 

  
 4 

 4. Disqualifying Disposition. If the Option is an Incentive Stock Option and if
within two years after the Grant Date or within 12 months after the exercise of the Option, the Optionee sells or otherwise disposes of Common Stock acquired on exercise of the Option, the Optionee shall within 30 days of the sale or
disposition notify the Company in writing of (i) the date of the sale or disposition, (ii) the amount realized on the sale or disposition and (iii) the nature of the disposition (e.g., sale, gift, etc.). 

5. Nontransferability. The Option is nonassignable and nontransferable by the Optionee, either voluntarily or by operation of law,
except by will or by the laws of descent and distribution of the state or country of the Optionee’s domicile at the time of death, and during the Optionee’s lifetime, the Option is exercisable only by the Optionee. 

6. Stock Splits, Stock Dividends. If the outstanding Common Stock of the Company is hereafter increased or decreased or changed
into or exchanged for a different number or kind of shares or other securities of the Company by reason of any stock split, combination of shares, dividend payable in shares, recapitalization or reclassification, appropriate adjustment shall be made
by the Company in (i) the number and kind of shares subject to the Option, or the unexercised portion thereof, and (ii) the Option price per share, so that the Optionee’s proportionate interest before and after the occurrence of the
event is maintained. Notwithstanding the foregoing, the Company shall have no obligation to effect any adjustment that would or might result in the issuance of fractional shares, and any fractional shares resulting from any adjustment may be
disregarded or provided for in any manner determined by the Company. Any such adjustments made by the Company shall be conclusive. 
 7. Mergers, Reorganizations, Etc. In the event of a merger, consolidation, plan of exchange, acquisition of property or stock, split-up, split-off, spin-off, reorganization or liquidation to
which the Company is a party or any sale, lease, exchange or other transfer (in one transaction or a series of related transactions) of all, or substantially all, of the assets of the Company (each, a “Transaction”), the Company shall, in
its sole discretion and to the extent possible under the structure of the Transaction, select one of the following alternatives for treating the Option: 
 7.1 The Option shall remain in effect in accordance with its terms. 
 7.2 The
Option shall be converted into an option to purchase stock in one or more of the corporations, including the Company, that are the surviving or acquiring corporations in the Transaction. The amount, type of securities subject thereto and exercise
price of the converted Options shall be determined by the Company, taking into account the relative values of the companies involved in the Transaction and the exchange rate, if any, used in determining shares of the surviving corporation(s) to be
held by holders of shares of the Company following the Transaction. The converted Option shall be vested only to the extent that the vesting requirements relating to the Option have been satisfied. 

7.3 The Company shall provide a period of 30 days or less before the completion of the Transaction during which the Option may be
exercised to the extent 

  
 5 

 
then exercisable, and upon the expiration of that period, the Option shall immediately terminate. The Company may, in its sole discretion, accelerate the exercisability of the Option so that the
Option is exercisable in full during that period. 
 8. Dissolution. In the event of the dissolution of the Company, the
Company shall provide a period of 30 days or less before the dissolution of the Company during which the Option may be exercised to the extent then exercisable, and upon the expiration of that period, the Option shall immediately terminate. The
Company may, in its sole discretion, accelerate the exercisability of the Option so that the Option is exercisable in full during that period. 
 9. Market Stand-off. The Optionee hereby agrees that it will not, without the prior written consent of the managing underwriter, during the period commencing on the date of the final prospectus
relating to the Company’s initial public offering and ending on the date specified by the Company and the managing underwriter (such period not to exceed one hundred eighty (180) days) (i) lend, offer, pledge, sell, contract to sell,
sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock or any securities convertible
into or exercisable or exchangeable for Common Stock (held immediately prior to the effectiveness of the registration statement for such offering), or (ii) enter into any swap or other arrangement that transfers to another, in whole or in part,
any of the economic consequences of ownership of the Common Stock, whether any such transaction described in clause (i) or (ii) above is to be settled by delivery of Common Stock or such other securities, in cash or otherwise. The
foregoing provisions of this Section 9 shall apply only to the Company’s initial public offering of equity securities, shall not apply to the sale of any shares to an underwriter pursuant to an underwriting agreement, and shall only be
applicable to the Optionee if all officers and directors and greater than one percent (1%) stockholders of the Company enter into similar agreements. The underwriters in connection with the Company’s initial public offering are intended
third party beneficiaries of this Section 9 and shall have the right, power and authority to enforce the provisions hereof as though they were a party hereto. 
 10. Right of First Refusal. 
 10.1 General. Any Shares of Common
Stock acquired by the Optionee upon exercise of this Option (“Option Shares”) are subject to a right of first refusal by the Company. In the event the Optionee desires to dispose of Option Shares to a third party, the Optionee shall
promptly deliver to the Company written notice of the intended disposition (the “Disposition Notice”) and the material terms and conditions thereof, including the identity of the proposed purchaser and the price per Share. The Company
shall, for a period of 30 days following receipt of the Disposition Notice, have the right to repurchase all or any portion of the Option Shares at the price and on the terms set forth in the Disposition Notice. Such right shall be exercisable
by written notice delivered to the Optionee prior to the expiration of the 30-day exercise period (“Exercise Notice”). If such right is exercised, the Company shall effect the repurchase of the Option Shares covered by the Exercise Notice,
including payment of the purchase price, not more than 

  
 6 

 
five business days after delivery of the Exercise Notice. At such time, the Optionee shall deliver to the Company any certificates representing the Option Shares to be purchased, each certificate
to be properly endorsed for transfer. If all of the Option Shares offered by the Optionee are not purchased by the Company, the Optionee shall have 30 days following lapse of the period of the right of first refusal provided to the Company to
dispose of all, but not less than all, of the remaining Option Shares to the purchaser identified in the Disposition Notice on terms no more favorable to the purchaser than those specified in the Disposition Notice. After such 30-day period lapses,
the Option Shares shall once again be subject to the right of first refusal herein provided. The right of the Company to purchase any part of the Option Shares under this Section 9.1 may be assigned in whole or in part to any person or persons
designated by the Board of Directors. 
 10.2 Restriction on Transfer. Without the prior written consent of the Company
or otherwise in compliance with subsection 9.1, the Optionee shall not sell, assign, pledge, or in any manner transfer the Option Shares, or any right or interest in the Option Shares, whether voluntarily or by operation of law, or by gift, bequest
or otherwise. Any sale or transfer, or purported sale or transfer, of Option Shares, or any right or interest in Option Shares, in violation of this Section 9.2 shall be null and void. 

10.3 Expiration. The rights of the Company under subsection 9.1 and the restriction on transfer under subsection 9.2 shall
terminate upon the completion by the Company of a public offering of Common Stock registered under the Securities Act of 1933. 

11. Restrictions on Transfer of Shares. Any shares purchased under this Option will be subject to the restrictions on transfer, if
any, included in the Company’s articles of incorporation and to any buy-sell agreement, shareholder agreement, stock transfer agreement or similar agreement then in effect between the Company and holders of at least a majority of the
Company’s outstanding common stock, and the Optionee agrees to become a party to any such agreement. 
 12. Conditions
on Obligations. The Company shall not be obligated to issue shares of Common Stock upon exercise of the Option if the Company is advised by its legal counsel that such issuance would violate applicable state or federal laws, including securities
laws. The Company will use its best efforts to take steps required by state or federal law or applicable regulations in connection with issuance of shares upon exercise of the Option. 

13. No Right to Employment or Service. Nothing in the Plan or this Agreement shall (i) confer upon the Optionee any right to
be continued in the employment of an Employer or interfere in any way with the Employer’s right to terminate the Optionee’s employment at will at any time, for any reason, with or without cause, or to decrease the Optionee’s
compensation or benefits, or (ii) confer upon the Optionee any right to be retained or employed by the Employer or to the continuation, 

  
 7 

 
extension, renewal or modification of any compensation, contract or arrangement with or by the Employer. 
 14. Successors of Company. This Agreement shall be binding upon and shall inure to the benefit of any successor of the Company but, except as provided herein, the Option may not be assigned or
otherwise transferred by the Optionee. 
 15. Notices. Any notices under this Agreement must be in writing and will be
effective when actually delivered or, if mailed, three days after deposit into the United States mail by registered or certified mail, postage prepaid. Mail shall be directed to the addresses stated on the face page of this Agreement or to such
address as a party may certify by notice to the other party. 
 16. Rights as a Stockholder. The Optionee shall have no
rights as a stockholder with respect to any shares of Common Stock until the date the Optionee becomes the holder of record of those shares. No adjustment shall be made for dividends or other rights for which the record date occurs before the date
the Optionee becomes the holder of record. 
 17. Amendments. The Company may at any time amend this Agreement if the
amendment does not adversely affect the Optionee. Otherwise, this Agreement may not be amended without the written consent of the Optionee and the Company. 
 18. Governing Law. This Agreement shall be governed by the laws of the state of Oregon. 
 19. Complete Agreement. This Agreement constitutes the entire agreement between the Optionee and the Company, both oral and written concerning the matters addressed herein, and all prior agreements
or representations concerning the matters addressed herein, whether written or oral, express or implied, are terminated and of no further effect. 

  
 8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00193-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00193-of-00352.parquet"}]]